Medications

Study debunks use of antidepressant Luvox as COVID treatment

A study testing drugs that are used for other conditions for their potential in treating COVID-19 has found that the antidepressant fluvoxamine (brand name Luvox) offered no benefit, at least at an initial smaller dose.

Psychology & Psychiatry

SSRIs and CBT lead to changes in brain

Neurochemical changes in the brain differ among patients with social anxiety treated using both SSRIs and CBT, compared to those treated using only CBT. While the combined treatment involving the medicine blocked the serotonin ...

Medical research

New insights into how serotonin regulates behavior

Rates of anxiety and depression have been increasing around the world for decades, a trend that has been sharply exacerbated by the COVID-19 pandemic. New research led by the Boyce Thompson Institute's Frank Schroeder could ...

page 8 from 40